Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2021 08:30 ET | Source: Antares Pharma, Inc.

Antares Pharma to Report First Quarter 2021 Financial and Operating Results

EWING, N.J., April 27, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced it will release its first quarter 2021...
April 26, 2021 08:30 ET | Source: Antares Pharma, Inc.

Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer

EWING, N.J., April 26, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced the appointment of Peter Richardson, MRCP, as...
March 02, 2021 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results

Full-Year 2020 Revenue Increases 21% Year-Over-Year to $149.6 Million Full-Year 2020 Net Income Before Income Taxes of $9.9 Million, or $0.06 per Share Full-Year 2020 Net Income of $56.2 Million,...
February 24, 2021 16:30 ET | Source: Antares Pharma, Inc.

Antares Pharma to Present at Two Upcoming Investor Conferences

EWING, N.J., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief...
February 23, 2021 08:30 ET | Source: Antares Pharma, Inc.

Antares Pharma to Report Fourth Quarter and Full-Year 2020 Financial and Operating Results

EWING, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced it will release its fourth quarter and...
February 17, 2021 08:30 ET | Source: Antares Pharma, Inc.

Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare Conference

EWING, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief...
January 11, 2021 08:00 ET | Source: Antares Pharma, Inc.

Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million

EWING, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced guidance for full-year 2021 and expects...
November 23, 2020 16:05 ET | Source: Antares Pharma, Inc.

Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief...
November 10, 2020 16:30 ET | Source: Antares Pharma, Inc.

Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference

EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief...
November 05, 2020 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results

Third Quarter 2020 Revenue Increases 17% Year-Over-Year to $40.0 Million Third Quarter 2020 Net Income of $5.0 Million, or EPS of $0.03 EWING, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) --...